• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板衍生生长因子-BB在皮肤纤维化模型中促进I型干扰素依赖性血管改变和单核细胞募集。

PDGF-BB Promotes Type I IFN-Dependent Vascular Alterations and Monocyte Recruitment in a Model of Dermal Fibrosis.

作者信息

Cho John S, Fang Terry C, Reynolds Taylor L, Sofia Daniel J, Hamann Stefan, Burkly Linda C

机构信息

Immunology Research, Biogen, Cambridge, MA, United States of America.

Translational Sciences - Pathology, Biogen, Cambridge, MA, United States of America.

出版信息

PLoS One. 2016 Sep 12;11(9):e0162758. doi: 10.1371/journal.pone.0162758. eCollection 2016.

DOI:10.1371/journal.pone.0162758
PMID:27618690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5019454/
Abstract

Systemic sclerosis (SSc) is a chronic autoimmune disorder that can result in extensive tissue damage in the skin and, in advanced cases, internal organs. Vasculopathy, aberrant immune activation, and tissue fibrosis are three hallmarks of the disease that have been identified, with vasculopathy and aberrant immunity being amongst the earliest events. However, a mechanistic link between these processes has not been established. Here, we have identified a novel role of platelet derived growth factor-BB (PDGF-BB)/PDGFRβ activation in combination with dermal injury induced by bleomycin as a driver of early, aberrant expression of interferon stimulatory genes (ISGs) and inflammatory monocyte infiltration. Activation of PDGFRβ in combination with bleomycin-induced dermal injury resulted in increased dermal thickness, vascular density, monocyte/macrophage infiltration, and exacerbation of tissue injury. Many of these features were dependent on IFNAR-signaling, and an increase in the number of interferon-beta (IFN-β) producing monocytes cells was found in the skin lesions. Taken together, these results identify a novel link between PDGFRβ activation, and Type I IFN-driven vascular maintenance and monocyte/macrophage cell recruitment, and provide a potential explanation linking key features of SSc that were previously thought to be unrelated.

摘要

系统性硬化症(SSc)是一种慢性自身免疫性疾病,可导致皮肤广泛组织损伤,在晚期病例中还可累及内脏器官。血管病变、异常免疫激活和组织纤维化是已确定的该疾病的三个特征,其中血管病变和异常免疫是最早出现的事件。然而,这些过程之间的机制联系尚未建立。在此,我们发现血小板衍生生长因子-BB(PDGF-BB)/血小板衍生生长因子受体β(PDGFRβ)激活与博来霉素诱导的皮肤损伤相结合,可作为干扰素刺激基因(ISGs)早期异常表达和炎性单核细胞浸润的驱动因素。PDGFRβ激活与博来霉素诱导的皮肤损伤相结合导致皮肤厚度增加、血管密度增加、单核细胞/巨噬细胞浸润以及组织损伤加重。这些特征中的许多都依赖于IFNAR信号传导,并且在皮肤病变中发现产生干扰素-β(IFN-β)的单核细胞数量增加。综上所述,这些结果确定了PDGFRβ激活与I型干扰素驱动的血管维持和单核细胞/巨噬细胞募集之间的新联系,并为之前认为无关的SSc关键特征之间的联系提供了潜在解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/cbde5dab479d/pone.0162758.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/07ca11369fce/pone.0162758.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/223c4f89cc3f/pone.0162758.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/a71edf03a535/pone.0162758.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/d20c5ee01fe6/pone.0162758.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/cbde5dab479d/pone.0162758.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/07ca11369fce/pone.0162758.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/223c4f89cc3f/pone.0162758.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/a71edf03a535/pone.0162758.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/d20c5ee01fe6/pone.0162758.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1728/5019454/cbde5dab479d/pone.0162758.g005.jpg

相似文献

1
PDGF-BB Promotes Type I IFN-Dependent Vascular Alterations and Monocyte Recruitment in a Model of Dermal Fibrosis.血小板衍生生长因子-BB在皮肤纤维化模型中促进I型干扰素依赖性血管改变和单核细胞募集。
PLoS One. 2016 Sep 12;11(9):e0162758. doi: 10.1371/journal.pone.0162758. eCollection 2016.
2
Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.伊马替尼治疗可预防系统性硬化症不同临床前模型中的纤维化,并促使已形成的纤维化消退。
Arthritis Rheum. 2009 Jan;60(1):219-24. doi: 10.1002/art.24186.
3
Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.甘草酸改善系统性硬化症动物模型中的纤维化、血管病变和炎症。
J Invest Dermatol. 2017 Mar;137(3):631-640. doi: 10.1016/j.jid.2016.08.037. Epub 2016 Oct 21.
4
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.阿巴西普治疗可预防实验性皮肤纤维化,并诱导已建立的炎症驱动性纤维化消退。
Ann Rheum Dis. 2016 Dec;75(12):2142-2149. doi: 10.1136/annrheumdis-2015-208213. Epub 2016 Feb 24.
5
The role of platelet-derived growth factor signaling in healing myocardial infarcts.血小板衍生生长因子信号在心肌梗死愈合中的作用。
J Am Coll Cardiol. 2006 Dec 5;48(11):2315-23. doi: 10.1016/j.jacc.2006.07.060. Epub 2006 Nov 13.
6
Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.博来霉素处理的 Fli-1 杂合不足小鼠中类似系统性硬化症的纤维化、血管活化和免疫异常。
Arthritis Rheumatol. 2015 Feb;67(2):517-26. doi: 10.1002/art.38948.
7
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis.Jun 氨基末端激酶作为预防和治疗皮肤纤维化的潜在分子靶标。
Ann Rheum Dis. 2012 May;71(5):737-45. doi: 10.1136/annrheumdis-2011-200412. Epub 2012 Jan 18.
8
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.核受体组成型雄烷受体/NR1I3 增强转化生长因子 β 的促纤维化作用,并有助于实验性皮肤纤维化的发展。
Arthritis Rheumatol. 2014 Nov;66(11):3140-50. doi: 10.1002/art.38819.
9
Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.舒尼替尼可抑制具有硬皮病样特征的小鼠皮肤中血小板衍生生长因子受体β的磷酸化,并预防疾病的发展。
Arthritis Rheum. 2012 Jun;64(6):1990-2000. doi: 10.1002/art.34354. Epub 2011 Dec 27.
10
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.内皮细胞向间充质转化促进系统性硬皮病的内皮功能障碍和皮肤纤维化。
Ann Rheum Dis. 2017 May;76(5):924-934. doi: 10.1136/annrheumdis-2016-210229. Epub 2017 Jan 6.

引用本文的文献

1
Periostin-An inducer of pro-fibrotic phenotype in monocytes and monocyte-derived macrophages in systemic sclerosis.骨膜蛋白——系统性硬化症中单核细胞和单核细胞来源的巨噬细胞中促纤维化表型的诱导剂。
PLoS One. 2023 Aug 2;18(8):e0281881. doi: 10.1371/journal.pone.0281881. eCollection 2023.
2
Upcoming treatments for morphea.即将出现的硬斑病治疗方法。
Immun Inflamm Dis. 2021 Dec;9(4):1101-1145. doi: 10.1002/iid3.475. Epub 2021 Jul 17.
3
Effects of a complex mixture prepared from agrimonia, houttuynia, licorice, peony, and phellodendron on human skin cells.

本文引用的文献

1
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial.尼洛替尼(达希纳™)治疗早期弥漫性系统性硬化症:一项开放标签的试点临床试验。
Arthritis Res Ther. 2015 Aug 18;17(1):213. doi: 10.1186/s13075-015-0721-3.
2
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.阿巴西普治疗可降低系统性硬化症患者的生物标志物水平并改善临床症状。
J Clin Invest. 2015 Jul 1;125(7):2795-807. doi: 10.1172/JCI77958. Epub 2015 Jun 22.
3
Activated STING in a vascular and pulmonary syndrome.
忍冬、鱼腥草、甘草、芍药、黄柏复合制剂对人皮肤细胞的影响。
Sci Rep. 2020 Dec 17;10(1):22132. doi: 10.1038/s41598-020-79301-2.
4
The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review.单核细胞和巨噬细胞在自身免疫性疾病中的作用:全面综述。
Front Immunol. 2019 May 24;10:1140. doi: 10.3389/fimmu.2019.01140. eCollection 2019.
5
Endostatin inhibits fibrosis by modulating the PDGFR/ERK signal pathway: an in vitro study.内皮抑素通过调节 PDGFR/ERK 信号通路抑制纤维化:一项体外研究。
J Zhejiang Univ Sci B. 2017;18(11):994-1001. doi: 10.1631/jzus.B1700052.
激活 STING 与血管和肺部综合征相关。
N Engl J Med. 2014 Aug 7;371(6):507-518. doi: 10.1056/NEJMoa1312625. Epub 2014 Jul 16.
4
The role of type 1 interferon in systemic sclerosis.1型干扰素在系统性硬化症中的作用。
Front Immunol. 2013 Sep 6;4:266. doi: 10.3389/fimmu.2013.00266.
5
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors.靶标激活水平可预测酪氨酸激酶抑制剂的抗纤维化反应。
Ann Rheum Dis. 2013 Dec;72(12):2039-46. doi: 10.1136/annrheumdis-2013-203729. Epub 2013 Sep 7.
6
A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling.一种合成的 TLR3 配体通过诱导自分泌 IFN 信号减轻促纤维化成纤维细胞反应。
J Immunol. 2013 Sep 15;191(6):2956-66. doi: 10.4049/jimmunol.1300376. Epub 2013 Aug 16.
7
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.血管内皮生长因子加重系统性硬化症实验模型中的纤维化和血管病变。
Ann Rheum Dis. 2014 Oct;73(10):1880-7. doi: 10.1136/annrheumdis-2013-203535. Epub 2013 Aug 5.
8
PDGFRβ signaling regulates mural cell plasticity and inhibits fat development.PDGFRβ 信号调节壁细胞可塑性并抑制脂肪发育。
Dev Cell. 2011 Jun 14;20(6):815-26. doi: 10.1016/j.devcel.2011.04.019.
9
Digital ischemic necrosis caused by pegylated interferon in a patient with hepatitis C.聚乙二醇干扰素导致的丙型肝炎患者数字缺血性坏死
World J Gastrointest Pharmacol Ther. 2011 Feb 6;2(1):6-8. doi: 10.4292/wjgpt.v2.i1.6.
10
The pathogenesis of systemic sclerosis.系统性硬化症的发病机制。
Annu Rev Pathol. 2011;6:509-37. doi: 10.1146/annurev-pathol-011110-130312.